β-Glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis
Open Access
- 6 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 157 (3) , 359-364
Abstract
We have demonstrated spontaneous development of autoimmune cholangitis, similar to human primary biliary cirrhosis, in mice expressing a dominant negative form of the transforming growth factor‐β receptor (dnTGF‐βRII) restricted to T cells. The autoimmune cholangitis appears to be mediated by autoreactive CD8+ T lymphocytes that home to the portal tracts and biliary system. Because the liver pathology is primarily secondary to CD8+ T cells, we have determined herein whether administration of β‐glucosylceramide (GC), a naturally occurring plant glycosphingolipid, alters the natural history of disease in this model. We chose GC because previous work has demonstrated its ability to alter CD8+ T cell responses and to down‐regulate tissue inflammation. Accordingly, dnTGF‐βRII mice were treated with either GC or control for a period of 18 weeks beginning at 6 weeks of age. Importantly, in mice that received GC, there was a significant decrease in the frequency and absolute number of autoreactive liver‐infiltrating CD8+ T cells, accompanied by a significant decrease in activated CD44high CD8+ T cell populations. Further, there was a significant reduction in portal inflammation in GC‐treated mice. Interestingly, there were no changes in anti‐mitochondrial antibodies, CD4+ T cells, CD19+ B cells or natural killer (NK) T cell populations, indicating further that the beneficial effects of GC on liver inflammation were targeted specifically to liver‐infiltrating CD8+ T cells. These data suggest that further work on GC in models of CD8+ T‐mediated inflammation are needed and point to a new therapeutic venue for potentially treating and/or modulating autoimmune disease.Keywords
This publication has 38 references indexed in Scilit:
- Lipid rafts and T‐lymphocyte function: Implications for autoimmunityFEBS Letters, 2008
- Modulation of intracellular machinery by β-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitisMolecular Immunology, 2008
- Adoptive transfer of CD8+ T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in miceHepatology, 2008
- Alleviation of Acute and Chronic Graft-Versus-Host Disease in a Murine Model Is Associated with Glucocerebroside-Enhanced Natural Killer T Lymphocyte PlasticityTransplantation, 2007
- β-Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disordersGut, 2006
- Autoreactive T-Cell Responses in Primary Biliary Cirrhosis Are Proinflammatory Whereas Those of Controls Are RegulatoryGastroenterology, 2006
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Quantitative and functional analysis of PDC-E2–specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosisJournal of Clinical Investigation, 2002
- Fine Specificity of T Cells Reactive to Human Pdc–E2 163–176 Peptide, the Immunodominant Autoantigen in Primary Biliary Cirrhosis: Implications for Molecular Mimicry and Cross–Recognition Among Mitochondrial AutoantigensHepatology, 2000
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999